Company / CapEx per Share
Sonoma Pharmaceuticals, Inc. CapEx per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.05
FY2026
5-year range
$0.00 / $0.09
FY2022-FY2026
Trend
+1810.0%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +1810% YoY in FY2026, a notable deviation from the 9-year average annual change of +206%.
Based on SEC 10-K filings.
0.05 in FY2026 with a 5-year CAGR of -15.8%.
Declined from $0.05 to $0.05 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- -15.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, capex per share increased 1810.0% year-over-year.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2025.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $0.05 | +1810.0% |
| FY2025 | $0.00 | -95.3% |
| FY2024 | $0.05 | +23.4% |
| FY2023 | $0.04 | -48.3% |
| FY2022 | $0.09 | -26.2% |
| FY2021 | $0.12 | +52.6% |
| FY2020 | $0.08 | -72.1% |
| FY2019 | $0.27 | +196.9% |
| FY2018 | $0.09 | +11.7% |
| FY2017 | $0.08 | +789.8% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026